On 6-7 November 2020 the inaugural Neuroblastoma Parent Global Symposium brought together families affected by neuroblastoma from around the world with those who work to treat, help and support them. 

Presentations from 36 experts from Australia, North America, and Europe shared the latest information on biology, treatment, research, late effects, and psychosocial challenges surrounding a childhood cancer diagnosis. Over 750 parents, medical professionals, charity leaders, and industry representatives from 47 countries were able to view live presentations, panel sessions, and ask questions.   

Families worldwide now have free access to information through 25 hours of recorded sessions which all can be viewed at www.nbparentsymposium.com.

International experts delivered sessions providing credible and reliable information on treatment and clinical trials, including current treatment strategies in Europe, North America and Australia, and some of the impacts of a childhood cancer diagnosis on the whole family.  

A prestigious Clinical Steering Committee oversaw the development of the comprehensive program, and was chaired by Daniel Morgenstern, MD. CSC members were Ami Dasai, MDCormac Owens, MDJuliet Grey, MA, MB, BS, PhDLucas Moreno, MD, PhDMichelle Haber, BSc, PhDNavin Pinto, MDSteven DuBois, MD, MSThorsten Simon MD, and Toby TrahairMD. 

Ahead of the event Dr. Lucas Moreno, member of the Clinical Steering Committee, said of the Symposium, “I strongly encourage families from all over the world to join this unique event. The event includes presentations of new advances in treatment, educational sessions, talks covering psychosocial aspects and how to facilitate access to innovative medicines.” 

Solving Kids’ Cancer UK has collaborated with Children’s Neuroblastoma Cancer Foundation and Solving Kids’ Cancer (US) (two charities with whom we have a history of collaboration) on this world-wide event - the first of its kind for the international neuroblastoma community.  

We are grateful to GRC World Forums, Y-mAbs TherapeuticsTHANC Foundation,  Sanofi and United Therapeutics for their support to help make this event possible. 

About the Symposium Partners 

Children’s Neuroblastoma Cancer Foundation 

The Children’s Neuroblastoma Cancer Foundation (CNCF) is the premier source for neuroblastoma information and resources.  

Comprised of families just like yours, we are committed to finding a cure for neuroblastoma through research, education, awareness and advocacy. Visit www.cncfhope.org to find out more about the work of CNCF. 

Solving Kids’ Cancer 

Solving Kids Cancer UK logoWe are a 
parent-led charity, our vision is for future where no child dies of neuroblastoma or suffers due to its treatment. 

As part of our mission Solving Kids’ Cancer initiates and funds innovative clinical research to provide children with the best and most promising new therapies available closer to home. Our research focus is on clinical trials, seeking to explore new ways of treating neuroblastoma, providing hope and options for children and their families now as well as building on the scientific understanding of this disease for children in the future. 

Solving Kids’ Cancer US 

Solving Kids Cancer US logoSolving Kids’ Cancer is not just our name, it’s our mission. We focus on aggressive childhood cancers with low survival rates - because Every Kid Deserves to Grow Up.  

Solving Kids' Cancer helps accelerate new clinical trials of next-generation treatments including immunotherapy,  biomarker-based targeted agents, and new combination therapies through research advocacy, with an understanding of the childhood cancer research landscape and current unmet needs to wisely invest in innovative projects.  Visit www.solvingkidcancer.org to learn more.